Incorporating pharmacoequity in the formulary review and evaluation process: Opportunities for health-system P&T committees to address health disparities and inequities

Authors

Donald C. Moore, Division of Pharmacy, Atrium Health Levine Cancer, Charlotte, NC, USA.
Angela Colella, Advocate Health - MidwestFollow
Janine S. Douglas, Intermountain Health, Salt Lake City, UT, USA.
Elizabeth A. Shlom, Institution, Lambertville, NJ, USA.
Joshua P. Vanderloo, UW Health, Madison, WI, USA.
Folashade Alabi, Medical Education, The Lockwood Group, Stamford, CT, USA.

Recommended Citation

Moore DC, Colella A, Douglas JS, Shlom EA, Vanderloo JP, Alabi F. Incorporating pharmacoequity in the formulary review and evaluation process: Opportunities for health-system P&T committees to address health disparities and inequities. Am J Health Syst Pharm. 2025;82(13):e637-e640. doi:10.1093/ajhp/zxae370

Document Type

Response or Comment

PubMed ID

39656923